Navigation Links
RSCI Announces World-Leading Stem Cell Science Advisory Board

The Repair Stem Cell Institute (RSCI) today announced its 2009 Science Advisory Board. Once again this year, every member of the SAB is a stem cell world-leader and has a world-first to his credit.

Dallas, Texas (PRWEB) May 27, 2009 -- The Repair Stem Cell Institute (RSCI), a Dallas, Texas-based stem cell global public affairs organization founded in April 2008, today announced the annual appointments of its Science Advisory Board (SAB) which consists of five of the world's leading Repair (Adult) Stem Cell treatment science and research professionals.

According to Don Margolis, RSCI Chairman, "RSCI's Science Advisory Board carries on our mission of providing the public with the latest Repair Stem Cell (RSC) research and therapeutic innovations. Repair Stem Cells include both autologous (from the patient) and cord blood. There is no organization in the world which can match these five leaders in stem cell treatment accomplishments---none. They actively research and successfully treat patients suffering from heart disease, cancer, diabetes, spinal cord injury, Multiple Sclerosis, ALS, and a dozen other incapacitating conditions with Repair Stem Cells. That covers over 90% of the world's incurable patients."

SAB Chairman Roberto Jorge Fernandez - Viña, M.D. is a world pioneer in developing stem cell therapies for heart diseases, Type 2 Diabetes, and serious lung disorders. He has treated hundreds of patients with stem cells for these conditions, both in his clinic in Argentina and in other clinics in Latin American countries. He proved the great healing benefit of RSC for heart patients in South American clinical trials in 2003-04, and is the first and only person with a successful clinical trial on treating Type 2 Diabetes with stem cells.

Professor Shimon Slavin, M.D., Deputy Chairman, is an expert bone marrow transplantation scientist and clinician, is famous for his innovative clinical application of cell-mediated immunotherapy for the treatment of cancers plus multiple sclerosis and ALS. He is the pioneer for all three. Dr. Slavin is the medical & scientific director of the International Center for Cell Therapy & Cancer (ICTC) at the Tel Aviv (Sourasky) Medical Center in Israel.

SAB Chairman Emeritus Kitipan V. Arom, M.D., Ph.D., FACS, FACC, FACCP, FRCST, established an innovative stem cell treatment program at Bangkok Heart Hospital (BHH) and may be the only doctor in the world to successfully inject stem cells directly into the heart muscles of more than 120 late-stage heart patients. Dr. Kit is the associate professor of surgery and chief cardiothoracic surgeon at BHH. He is a co-founder of the Minneapolis Heart and is the President of the Society of Thoracic Surgeons of Thailand.

Carlos Lima, M.D., one of the foremost neuropathologist experts in stem cell treatments, rejected traditional bone marrow stem cells as a too-limited source for the neurological stem cells required to repair injured spinal cords. Using olfactory stem cells harvested from the patient's own nose, Dr. Lima transplants the cells at the spinal cord break utilizing the successful OMA transplant surgical procedure he developed. He was the first doctor in the world whose treatments, coupled with extensive rehabilitation therapy, created the neurological redevelopment required to allow some paraplegics to rise from their wheelchairs and walk.

Zannos G. Grekos, M.D., F.A.A.C. Director of Cardiology & Vascular Disease, Regenocyte and Clinical Assistant Professor, Nova Southeastern University, is an RSC innovator. Dr. Grekos is the first to inject stem cells into the muscle of the heart via catheterization. This procedure produces significantly less "spillage," maximizing cell utilization at the target region. In May he saved a young cardiomyopathy patient with serious complications by developing a new multi-faceted comprehensive stem cell treatment procedure. Dr. Grekos treats pulmonary hypertension and fibrosis, heart and peripheral vascular diseases, and is the only doctor known to have a successful stem cell therapy for renal problems.

"To summarize," said Mr. Margolis, "these five men have improved the lives of more 'untreatable' patients than all of the world's thousands of embryonic doctors and scientists combined---and that will still be true a decade from now!"

About The Repair Stem Cell Institute: The Repair Stem Cell Institute's mission is to educate and inform everyone about the rapid advances being made in Repair Stem Cell research, so all can intelligently exercise freedom of choice in medical care. If you, or a loved one, is seeking treatment for your "untreatable" medical condition and wish to avoid less competent stem cell clinics, visit for our list of the eight most experienced and successful stem cell treatment centers in the world, as well as the standards applied to them.


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford
2. Simcere Pharmaceutical Group Announces Agreement to Acquire 37.5% Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd.
3. Beactica Announces Drug Discovery Agreement With Cubist Pharmaceuticals
4. Transgenomic, Inc. Announces Appointment of New Board Members
5. Johnson & Johnson Announces Definitive Agreement to Acquire Cougar Biotechnology, Inc.
6. American Acne & Rosacea Society Announces Acne Awareness Month - June 2009
7. Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes
8. Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer
9. Aesthera Announces ANVISA Clearance to Market Photopneumatic Platforms in Brazil
10. Oncothyreon announces commitments to purchase $11.1 million of company securities in a registered direct financing
11. Beckman Coulter, Inc. Announces Pricing of Common Stock Offering
Post Your Comments:
Related Image:
RSCI Announces World-Leading Stem Cell Science Advisory Board
(Date:11/24/2015)... ... 2015 , ... Copper is an essential micronutrient that all ... copper is also toxic to cells. With a $1.3 million award from the ... a systematic study of copper in the bacteria Pseudomonas aeruginosa (P. aeruginosa), a ...
(Date:11/24/2015)... ... November 24, 2015 , ... This fall, global software solutions ... in five states to develop and pitch their BIG ideas to improve health and ... are competing for votes to win the title of SAP's Teen Innovator, an all-expenses ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... that the remaining 11,000 post-share consolidation (or 1,100,000 ... (the "Series B Warrants") subject to the previously ... November 23, 2015, which will result in the ... effect to the issuance of such shares, there ...
(Date:11/24/2015)... 2015 /CNW Telbec/ - ProMetic Life Sciences Inc. (TSX: PLI) ... Pierre Laurin , President and Chief Executive Officer of ... Piper Jaffray 27 th Annual Healthcare Conference to be ... 2015. st , at 8.50am (ET) and ... the day. The presentation will be available live via a ...
Breaking Biology Technology:
(Date:11/19/2015)...  Although some 350 companies are actively involved in ... companies, according to Kalorama Information. These include Roche Diagnostics, Hologic, ... share of the 6.1 billion-dollar molecular testing market, according ... Molecular Diagnostic s .    ... by one company and only a handful of companies ...
(Date:11/17/2015)... Paris from 17 th ... Paris from 17 th until 19 th ... leader, has invented the first combined scanner in the world ... scanning surface. Until now two different scanners were required: one ... both on the same surface. This innovation is an ...
(Date:11/17/2015)... , Nov. 17, 2015 Pressure BioSciences, ... in the development and sale of broadly enabling, pressure ... life sciences industry, today announced it has received gross ... $5 million Private Placement (the "Offering"), increasing the total ...  One or more additional closings are expected in the ...
Breaking Biology News(10 mins):